60 Degrees Pharmaceuticals Inc (SXTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2023 | 12-2022 | 09-2022 | 06-2022 | 12-2021 | |
Sales | 22 | 0 | 318 | 37 | 0 |
Cost of Goods | 73 | N/A | 92 | 87 | N/A |
Gross Profit | -52 | N/A | 226 | -50 | N/A |
Operating Expenses | 972 | 0 | 534 | 724 | 0 |
Operating Income | -951 | N/A | -215 | -687 | N/A |
Interest Expense | 1,141 | 0 | 1,216 | 906 | 0 |
Other Income | -505 | 0 | -19 | -557 | 0 |
Pre-tax Income | -2,598 | 0 | -1,450 | -2,150 | 0 |
Net Income Continuous | -2,598 | N/A | -1,451 | -2,150 | N/A |
Minority Interests | 3 | N/A | -3 | -3 | N/A |
Net Income | $-2,600 | $N/A | $-1,448 | $-2,147 | $N/A |
EPS Basic Total Ops | -13.57 | N/A | -7.32 | -11.52 | N/A |
EPS Basic Continuous Ops | -13.53 | N/A | -7.30 | -10.99 | N/A |
EPS Diluted Total Ops | -13.57 | N/A | -7.32 | -11.52 | N/A |
EPS Diluted Continuous Ops | -13.53 | N/A | -7.30 | -10.99 | N/A |
EBITDA(a) | $-228 | $N/A | $287 | $-687 | $N/A |